Search for: "Pfizer Inc. v. United States Of America" Results 1 - 20 of 56
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Feb 2022, 9:16 am by Matrix Legal Support Service
On Wednesday 23rd February, judgment will be handed down in Craig (AP) v Her Majesty’s Advocate (for the Government of the United States of America) and another, on appeal from [2020] HCJAC 22. [read post]
23 Aug 2021, 2:12 am by Radhi Shah (USC Gould School of Law)
28 U.S.C § 1498 (a) (Governmental Use) The United States (U.S.) does not have any provisions for a compulsory license. [read post]
13 Jul 2021, 10:58 am by Simon Lester
In the United States (US), as for most developed countries,[6] trade policy and IP standards have consistently been linked, a pattern which can (at least partially) be traced back to extensive lobbying by senior management at US-based technology and pharmaceutical firms.[7] For example, since at least the 1980s, Pfizer Inc. has been involved in mobilizing other US firms and stakeholders to lobby US policymakers on the issue of international IP protection. [read post]
17 Mar 2020, 1:32 pm by Noble McIntyre
Twelve Lots of CHANTIX® (Varenicline) Tablets have been recalled by Pfizer due to N-Nitroso Varenicline content above ADI level. [read post]
30 Jun 2015, 2:57 am by Rebecca Tushnet
Perhaps worse, this standard is stated as being the standard for the Lanham Act in a state law consumer protection case, with citation of but no apparent comprehension of the difference between literal falsity and literal truth that is nonetheless misleading. [read post]
12 Jun 2014, 3:11 pm by Schachtman
Pfizer Pharms., Inc., 2011 WL 7659333, at *6-10 (S.D. [read post]
1 Mar 2014, 8:55 pm by James Yang
  During an interference proceeding before the United States Patent and Trademark Office, now obviated under the first to file rules of the American Invents Act, Pfizer presented documentary and testimonial evidence that it had isolated and identified the desired cDNA before the Sanofi benefit date. [read post]
2 Apr 2012, 6:15 am by Mandelman
(In case you’re wondering, the remaining five are Microsoft, Pfizer, Exxon-Mobil, Johnson & Johnson and ADP.) [read post]
2 Jun 2011, 12:46 pm by Bexis
Pfizer, Inc., 153 S.W.3d 758, 761 (Ky. 2004) (dictum also extends rule to medical devices). [read post]
28 Apr 2011, 3:18 pm by Bexis
 At least the state of the art at the time of the plaintiff’s use applies – unknown and later discovered risks are irrelevant. [read post]
22 Jun 2010, 12:41 pm by Erin Miller
Amicus brief of Paralyzed Veterans of America Amicus brief of the United Spinal Association Title: Kentucky Baptist Homes for Children, Inc. v. [read post]
25 Jan 2010, 5:00 am by Beck, et al.
Mid-America Racing Stables, Inc., 139 F.R.D. 405, 410-11 (W.D. [read post]